Literature DB >> 31415899

Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.

Antonia M S Müller1, Dullei Min2, Gerlinde Wernig3, Robert B Levy4, Victor L Perez5, Samantha Herretes5, Mareike Florek6, Casey Burnett6, Kenneth Weinberg7, Judith A Shizuru8.   

Abstract

Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic cell transplantation. Acute GVHD (aGVHD) results from direct damage by donor T cells, whereas the biology of chronic GVHD (cGVHD) with its autoimmune-like manifestations remains poorly understood, mainly because of the paucity of representative preclinical models. We examined over an extended time period 7 MHC-matched, minor antigen-mismatched mouse models for development of cGVHD. Development and manifestations of cGVHD were determined by a combination of MHC allele type and recipient strain, with BALB recipients being the most susceptible. The C57BL/6 into BALB.B combination most closely modeled the human syndrome. In this strain combination moderate aGVHD was observed and BALB.B survivors developed overt cGVHD at 6 to 12 months affecting eyes, skin, and liver. Naïve CD4+ cells caused this syndrome as no significant pathology was induced by grafts composed of purified hematopoietic stem cells (HSCs) or HSC plus effector memory CD4+ or CD8+ cells. Furthermore, co-transferred naïve and effector memory CD4+ T cells demonstrated differential homing patterns and locations of persistence. No clear association with donor Th17 cells and the phenotype of aGVHD or cGVHD was observed in this model. Donor CD4+ cells caused injury to medullary thymic epithelial cells, a key population responsible for negative T cell selection, suggesting that impaired thymic selection was an underlying cause of the cGVHD syndrome. In conclusion, we report for the first time that the C57BL/6 into BALB.B combination is a representative model of cGVHD that evolves from immunologic events during the early post-transplant period.
Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic graft-versus-host disease; Mouse models; Pathophysiology; Thymic damage

Mesh:

Substances:

Year:  2019        PMID: 31415899     DOI: 10.1016/j.bbmt.2019.08.001

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  4 in total

Review 1.  Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.

Authors:  Patricia A Shi; Larry L Luchsinger; John M Greally; Colleen S Delaney
Journal:  Curr Opin Hematol       Date:  2022-08-29       Impact factor: 3.218

Review 2.  H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.

Authors:  Eun Young Choi; Kyungho Choi; Giri Nam; Woojin Kim; Minho Chung
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561

Review 3.  Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease.

Authors:  Chao Hong; Rong Jin; Xiaoqiu Dai; Xiaoming Gao
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

4.  Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis.

Authors:  Uta Gehlsen; Daniela Stary; Martina Maass; Katarina Riesner; Gwen Musial; Michael E Stern; Olaf Penack; Philipp Steven
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.